Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2004;94:e17
doi: 10.1161/01.RES.0000115311.56442.A6
This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsuda, K.
Right arrow Articles by Nishio, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsuda, K.
Right arrow Articles by Nishio, I.
(Circulation Research. 2004;94:e17.)
© 2004 American Heart Association, Inc.


Letters to the Editor

Role of Estrogens in the Regulation of Membrane Microviscosity

Kazushi Tsuda, Ichiro Nishio

Division of Cardiology, Department of Medicine, Wakayama Medical University, Wakayama, Japan, tsudak{at}mail.wakayama-med.ac.jp

To the Editor:

We read with great interest the recent article by Lew and colleagues1 dealing with the relationship between estrogens and endothelial function in men. The results of their study demonstrated that the suppression of endogenous estrogens with an aromatase inhibitor, anastrozole, resulted in impairment of flow-mediated dilatation of the brachial artery in healthy young men. The authors proposed that estrogens might play a direct regulatory role in endothelial function not only in women but also in men.

There is evidence that estrogens might actively participate in the regulation of membrane function. Whiting et al2 demonstrated the nongenomic effects of steroid hormones on phosphatidylcholine liposome, synaptosomal plasma membranes, and sarcoplasmic reticulum membranes. In the studies we presented earlier, a relationship between membrane fluidity (a reciprocal value of membrane microviscosity) of erythrocytes and estrogens was investigated by means of an electron paramagnetic resonance method. The decreased membrane fluidity of erythrocytes might cause a disturbance in the blood rheologic behavior and the microcirculation, which could contribute, at least in part, to the pathophysiology of circulatory disorders. We demonstrated that hormone (estrogen) replacement therapy significantly increased the membrane fluidity of erythrocytes with a concomitant increase in plasma nitric oxide (NO) metabolite level in postmenopausal women.3 In an in vitro study, we showed that 17ß-estradiol, estrone, and estriol increased the membrane fluidity of erythrocytes and improved the rigidity of cell membranes via the NO- and cGMP-dependent mechanism not only in women but also in men.4–6 One hypothesis is that the membrane action of estrogens could be one of the mechanisms responsible for their beneficial effects on the rheologic properties of erythrocyte membranes. In this context, we speculate that estrogen-induced NO production might modulate the membrane microviscosity both in men and women, which could partially explain the preventing effect of estrogens against the vascular complications. It would be necessary to assess more precisely the functional interactions between estrogens and NO in the regulation of membrane microviscosity and their contribution to the vascular function both in men and women.

References

1. Lew R, Komesaroff P, Williams M, Dawood T, Sudhir K. Endogenous estrogens influence endothelial function in young men. Circ Res. 2003; 93: 1127–1133.[Abstract/Free Full Text]

2. Whiting KP, Restall CJ, Brain PF. Steroid hormone-induced effects on membrane fluidity and their potential roles in non-genomic mechanisms. Life Sci. 2000; 67: 743–757.[CrossRef][Medline] [Order article via Infotrieve]

3. Tsuda K, Kinoshita-Shimamoto Y, Mabuchi Y, Nishio I. Hormone replacement therapy improves membrane fluidity of erythrocytes in postmenopausal women: an electron paramagnetic resonance investigation. Am J Hypertens. 2003; 16: 502–507.[CrossRef][Medline] [Order article via Infotrieve]

4. Tsuda K, Kinoshita Y, Kimura K, Nishio I, Masuyama Y. Electron paramagnetic resonance investigation on modulatory effect of 17ß-estradiol on membrane fluidity of erythrocytes in postmenopausal women. Arterioscler Thromb Vas Biol. 2001; 21: 1306–1312.[Abstract/Free Full Text]

5. Tsuda K, Kinoshita-Shimamoto Y, Kimura K, Nishio I. Effect of oestrone on membrane fluidity of erythrocytes is mediated by a nitric oxide-dependent pathway: an electron paramagnetic resonance study. Clin Exp Pharmacol Physiol. 2002; 29: 972–979.[CrossRef][Medline] [Order article via Infotrieve]

6. Tsuda K, Shimamoto Y, Kimura K, Nishio I, Masuyama Y. Estriol improves membrane fluidity of erythrocytes by the nitric oxide-dependent mechanism: an electron paramagnetic resonance study. Hypertens Res. 2001; 24: 263–269.[CrossRef][Medline] [Order article via Infotrieve]





This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsuda, K.
Right arrow Articles by Nishio, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsuda, K.
Right arrow Articles by Nishio, I.